News European Medicines Agency reveals favoured cities for reloca... Amsterdam, Barcelona, Copenhagen, Milan, or Vienna top staff survey.
Views & Analysis PRIME movers: taking stock of the EMA's scheme Taking stock of one PRIME, of the EMA’s flagship market access initiatives.
News Deadline looms for EMA host city bids Europe's medicines regulator will move from London after Brexit
Views & Analysis Macron’s France: advancing towards a European vision for hea... What will Macron's government mean for healthcare in his country and Europe?
News Pharma facing uncertainty as May triggers Brexit The UK government will shortly trigger Brexit under Article 50, opening up negotiations which are expected to see the country leave the European Union by March 2019.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
